[1] |
NORDBERG A.Dementia in 2014. Towards early diagnosis in Alzheimer disease[J]. Nat Rev Neurol,2015,11(2): 69-70.
|
[2] |
RICHARTZ E,STRANSKY E,BATRA A,et al.Decline of immune responsiveness:a pathogenetic factor in Alzheimer's disease?[J]. J Psychiatr Res,2005,39(5):535-543.
|
[3] |
MÜLLER N,SCHWARZ M J. Neuroimmune-endocrine crosstalk in schizophrenia and mood disorders[J]. Expert Rev Neurother,2006,6(7): 1017-1038.
|
[4] |
SHAHBAZI S,KAUR J,KUANAR A,et al.Risk of late-onset Alzheimer's disease by plasma cholesterol:rational in silico drug investigation of pyrrole-based HMG-CoA reductase inhibitors[J]. Assay Drug Dev Technol,2017,15(7):342-351.
|
[5] |
BORRONI B,COLCIAGHI F,LENZI G L,et al.High cholesterol affects platelet APP processing in controls and in AD patients[J]. Neurobiol Aging,2003,24(5):631-636.
|
[6] |
SOLOMON A,KIVIPELTO M,WOLOZIN B,et al.Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later[J]. Dement Geriatr Cogn Disord,2009,28(1):75-80.
|
[7] |
PAPPOLLA M A,BRYANT-THOMAS T K,HERBERT D,et al. Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology[J]. Nueurology,2003,61(2):199-205.
|
[8] |
D'ANNA L,ABU-RUMEILEH S,FABRIS M,et al. Serum interleukin-10 levels correlate with cerebrospinal fluid amyloid beta deposition in Alzheimer disease patients[J]. Neurodegener Dis,2017,17(4-5):227-234.
|
[9] |
BAGYINSZKY E,GIAU V V,SHIM K,et al.Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis[J]. J Neurol Sci,2017,376:242-254.
|
[10] |
DOMINGUES C,DA CRUZ E SILVA OAB,HENRIQUES A G. Impact of cytokines and chemokines on Alzheimer's disease neuropathological hallmarks[J]. Curr Alzheimer Res,2017,14(8):870-882.
|
[11] |
MCNAULL B B,TODD S,MCGUINNESS B,et al.Inflammation and anti-inflammatory strategies for Alzheimer's disease-a mini-review[J]. Gerontology,2010,56(1):3-14.
|
[12] |
JULIAN A,DUGAST E,RAGOT S,et al.There is no correlation between peripheral inflammation and cognitive status at diagnosis in Alzheimer's disease[J]. Aging Clin Exp Res,2015,27(5):589-594.
|
[13] |
SARESELLA M,MARVENTANO I,CALABRESE E,et al.A complex proinflammatory role for peripheral monocytes in Alzheimer's disease[J]. J Alzheimers Dis,2014,38(2):403-413.
|
[14] |
YAMADA A,AKIMOTO H,KAGAWA S,et al.Proinflammatory cytokine interferon-gamma increases induction of indoleamine 2,3-dioxygenase in monocytic cells primed with amyloid beta peptide 1-42:implications for the pathogenesis of Alzheimer's disease[J]. J Neurochem,2009,110(3):791-800.
|
[15] |
DURSUN E,GEZEN-AK D,HANAASI H,et al.The interleukin 1 alpha,interleukin 1 beta,interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease,mild cognitive impairment or Parkinson's disease[J]. J Neuroimmunol,2015,283:50-57.
|
[16] |
HELMY A A,NASEER M M,SHAFIE S E,et al.Role of interleukin 6 and alpha-globulins in differentiating Alzheimer and vascular dementias[J]. Neurodegener Dis,2012,9(2):81-86.
|
[17] |
COJOCARU I M,COJOCARU M,MIU G,et al.Study of interleukin-6 production in Alzheimer's disease[J]. Rom J Intern Med,2011,49(1):55-58.
|
[18] |
GEZEN-AK D,DURSUN E,HANAASI H,et al.BDNF,TNFα,HSP90,CFH,and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment[J]. J Alzheimers Dis,2013,37(1):185-195.
|